Seeing Is Believing

Currently out of the existing stock ratings of Justin Kim, 81 are a BUY (92.05%), 7 are a HOLD (7.95%).
Analyst Justin Kim, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 60.52% that have a potential upside of 63.38% achieved within 303 days.
Justin Kim’s has documented 167 price targets and ratings displayed on 15 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on PHVS, Pharvaris BV at 04-Dec-2025.
Analyst best performing recommendations are on VERA (VERA THERAPEUTICS).
The best stock recommendation documented was for VERA (VERA THERAPEUTICS) at 1/24/2024. The price target of $26 was fulfilled within 2 days with a profit of $8.98 (52.76%) receiving and performance score of 263.81.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 18-Jul-2022
$280
3 years 8 months 12 days ago
(18-Jul-2022)
0/4 (0%)
$267.6 (2158.06%)
Hold Since 30-Jun-2022
$50
$40 (400.00%)
$150
3 years 9 months ago
(30-Jun-2022)
0/4 (0%)
$38.6 (338.60%)
Hold Since 30-Jun-2022
3 years 9 months ago
(30-Jun-2022)
0/2 (0%)
$53.9 (206.51%)
Which stock is Justin Kim is most bullish on?
What Year was the first public recommendation made by Justin Kim?